Amit Sachdev, EVP Chief Patient & Ext Af Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 32 shares at $430.93 ($14K) on 2024-05-15, disclosed to the SEC on 2024-05-17.
Scheduled sale ($14k) by EVP Chief Patient & Ext Af Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $3.6M | — | Filing → |